Interstitial lung diseases and COVID‐19 pneumonia

Journal of Medical VirologyVolume 95, Issue 11 e29207 LETTER TO THE EDITOR Interstitial lung diseases and COVID-19 pneumonia Ranjeet S. Mahla, Corresponding Author Ranjeet S. Mahla [email protected] orcid.org/0000-0002-5525-8442 Kennedy Institute of Rheumatology (KIR), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), Medical Science Division, University of Oxford, Oxford, UK Correspondence Ranjeet S. Mahla, Kennedy Institute of Rheumatology (KIR), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Old Rd Campus, Roosevelt Dr, Headington, OX3 7FY, Oxford, UK. Email: [email protected]Search for more papers by this author Ranjeet S. Mahla, Corresponding Author Ranjeet S. Mahla [email protected] orcid.org/0000-0002-5525-8442 Kennedy Institute of Rheumatology (KIR), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), Medical Science Division, University of Oxford, Oxford, UK Correspondence Ranjeet S. Mahla, Kennedy Institute of Rheumatology (KIR), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Old Rd Campus, Roosevelt Dr, Headington, OX3 7FY, Oxford, UK. Email: [email protected]Search for more papers by this author First published: 02 November 2023 https://doi.org/10.1002/jmv.29207Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Shao C, Shi Y, Chen R, et al. Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic. J Med Virol. 2023; 95:e29098. doi:10.1002/jmv.29098 10.1002/jmv.29098 CASPubMedWeb of Science®Google Scholar 2Gunay S, et al Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up. Sarcoidosis Vasc Diffuse Lung Dis. 2023; 40:e2023029. doi:10.36141/svdld.v40i3.14418 PubMedGoogle Scholar 3DeDent AM, Farrand E. Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination. Thorax. 2022; 77: 9-10. doi:10.1136/thoraxjnl-2021-217985 10.1136/thoraxjnl-2021-217985 PubMedWeb of Science®Google Scholar 4Mackintosh JA, Wells AU, Cottin V, Nicholson AG, Renzoni EA. Interstitial pneumonia with autoimmune features: challenges and controversies. Eur Respir Rev. 2021; 30:210177. doi:10.1183/16000617.0177-2021 10.1183/16000617.0177-2021 PubMedWeb of Science®Google Scholar 5 World Health Organization. WHO – COVID-19 Vaccine Tracker. 2023. Accessed December 17, 2023. https://covid19.trackvaccines.org/agency/who/ Google Scholar 6Amiya S, Fujimoto J, Matsumoto K, et al. Case report: acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination. Int J Infect Dis. 2022; 116: 255-257. doi:10.1016/j.ijid.2022.01.031 10.1016/j.ijid.2022.01.031 CASPubMedWeb of Science®Google Scholar 7Sattui SE, Liew JW, Kennedy K, et al. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. 2021; 7:e001814. doi:10.1136/rmdopen-2021-001814 10.1136/rmdopen-2021-001814 PubMedWeb of Science®Google Scholar 8Liossis SNC, Bounia CA. Treating autoimmune-related interstitial lung disease with B cell depletion. Front Med. 2022; 9:937561. doi:10.3389/fmed.2022.937561 10.3389/fmed.2022.937561 Web of Science®Google Scholar 9Peng K, Li X, Yang D, et al. Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study. EClinicalMedicine. 2023; 63:102154. doi:10.1016/j.eclinm.2023.102154 10.1016/j.eclinm.2023.102154 PubMedGoogle Scholar 10Valenzuela C, Waterer G, Raghu G. Interstitial lung disease before and after COVID-19: a double threat? Eur Respir J. 2021; 58:2101956. doi:10.1183/13993003.01956-2021 10.1183/13993003.01956-2021 CASPubMedGoogle Scholar Volume95, Issue11November 2023e29207 ReferencesRelatedInformation